We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BARC:LSEBarclays PLC analysis

Data as of Oct 20, 2026 - not real-time

Latest price
£409.75
Risk: medium
4/10Medium risk

Summary

At £409.75, Barclays PLC shows no decisive moving-average alignment, leaving the trend neutral. Over a rolling month the price has lost 17.7%. Relative strength is 26.0 — oversold — and the MACD signal is bearish. Price has been bracketed by support at £408.85 and resistance at £503.00.
Multiples put this in undervalued territory: 8.5 times earnings against the sector's 15.7. Analyst price targets sit 39.9% above the current price. Revenue is growing at 15.6% on a 27.9% profit margin. The 2.75% dividend yield looks covered by current payout levels.
Risk scores 4 out of 10, which is moderate for this asset class. With 30-day volatility of 27.5%, a beta of 0.68 and a maximum drawdown of 25.5%, position sizing matters here. The wider market backdrop reads extreme greed at 88 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 6 out of 10.

Top market events

  • Barclays has given shareholders a powerful ride over the last three years, yet the latest pullback and fresh regulatory...
  • Kalkine Media3dFTSE 100 Barclays LSE:BARC : Dividend Ahead of ResultsThe growth streak dates from the period after the...
  • Barclays shares have suffered a sharp pullback in recent months.

Market outlook

Short term

< 1 year

Neutral

Model confidence3/103 out of 10

Key factors

  • RSI at 26.0 signals oversold conditions
  • Trading below the 200-day average of 465.21
  • MACD momentum is negative

Medium term

1–3 years

Positive

Model confidence4/104 out of 10

Key factors

  • RSI at 26.0 signals oversold conditions
  • P/E of 8.5 versus sector average of 15.7
  • Trading below the 200-day average of 465.21

Long term

> 3 years

Positive

Model confidence6/106 out of 10

Key factors

  • P/E of 8.5 versus sector average of 15.7
  • Analyst targets imply +39.9% versus the current price
  • Profit margin of 27.9% is healthy

Key metrics

Financial health

Revenue Growth15.60%
Profit Margin27.87%
P/E Ratio8.5
ROE10.09%
ROA0.47%
P/B Ratio0.8
Op. Cash Flow£-949000000
Industry P/E15.7

Technical analysis

TrendNeutral
RSI26.0
Support£408.85
Resistance£503.00
MA 20£441.11
MA 50£471.98
MA 200£465.21
MACDBearish
VolumeIncreasing
Fear & Greed Index87.98

Valuation

Target Price£573.41
Upside/Downside39.94%
GradeUndervalued
TypeBlend
Dividend Yield2.75%

Risk assessment

Beta0.68
Volatility27.53%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.